I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Phase 2, multicenter, open‐label study of tigatuzumab (CS‐1..:
Forero‐Torres, Andres
;
Infante, Jeffrey R.
;
Waterhouse, David
...
Cancer Medicine. 2 (2013) 6 - p. 925-932 , 2013
Link:
https://doi.org/10.1002/cam4.137
RT Journal T1
Phase 2, multicenter, open‐label study of tigatuzumab (CS‐1008), a humanized monoclonal antibody targeting death receptor 5, in combination with gemcitabine in chemotherapy‐naive patients with unresectable or metastatic pancreatic cancer
UL https://suche.suub.uni-bremen.de/peid=cr-10.1002_cam4.137&Exemplar=1&LAN=DE A1 Forero‐Torres, Andres A1 Infante, Jeffrey R. A1 Waterhouse, David A1 Wong, Lucas A1 Vickers, Selwyn A1 Arrowsmith, Edward A1 He, Aiwu Ruth A1 Hart, Lowell A1 Trent, David A1 Wade, James A1 Jin, Xiaoping A1 Wang, Qiang A1 Austin, TaShara A1 Rosen, Michael A1 Beckman, Robert A1 von Roemeling, Reinhard A1 Greenberg, Jonathan A1 Saleh, Mansoor PB Wiley YR 2013 SN 2045-7634 SN 2045-7634 JF Cancer Medicine VO 2 IS 6 SP 925 OP 932 LK http://dx.doi.org/https://doi.org/10.1002/cam4.137 DO https://doi.org/10.1002/cam4.137 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)